COMMUNIQUÉS West-GlobeNewswire

DBV Technologies annonce le screening du premier participant de l’étude clinique de phase 2 THRIVE pour le patch VIASKIN® Peanut chez les nourrissons âgés de 6 à 12 mois allergiques à l’arachide
03/06/2026
Châtillon, France, le 02 juin (22 :30 CEST) 2026 DBV Technologies annonce le screening du premier participant de l’étude clinique de phase 2 THRIVE pour le patch VIASKIN ® Peanut chez les nourrissons âgés de 6 à 12 mois [...]
Zenas BioPharma Announces Data from the Registrational Phase 3 INDIGO Trial of Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD), Simultaneously Presented at the EULAR 2026 Congress and Published in the New England Journal of Medicine
03/06/2026
- The INDIGO study met its primary and all key secondary endpoints with statistically significant results - - Obexelimab significantly lowered the total amount of glucocorticoid use and reduced glucocorticoid-related [...]
Alamar Biosciences Makes Home-Collected Fingerstick Samples Compatible with Ultra High-Sensitivity, Multiplex Proteomics
02/06/2026
NULISA™ DBS Extraction Kit recovers proteins from dried blood spot and dried plasma spot microsamples collected on leading third-party remote sampling devices Workflow extends NULISA into longitudinal, decentralized, [...]
INVO Fertility Receives Nasdaq Notification Regarding Late Filing of Quarterly Report on Form 10-Q
02/06/2026
SARASOTA, Fla., June 02, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO” or the “Company”), a healthcare services fertility company, today announced that on May 27, 2026, it received a delinquency [...]
Syndax Highlights Revuforj® (revumenib) Data Presented at ASCO 2026, Including an Oral Presentation of Post-Transplant Data
02/06/2026
– Pooled analysis of 24 adults and children with KMT2Ar, NPM1m, or NUP98r acute leukemia who resumed revumenib post-transplant shows favorable outcomes, including a 2-year overall survival rate of 90% vs historical [...]
J-Star Holding Outlines Foundational Milestones Supporting Proposed Baytown Battery Manufacturing Facility
02/06/2026
Taiwan Central Bank Authorization and EDF Site Commitment Add New Support for Project Under Active DOE Review TAICHUNG CITY, Taiwan, June 02, 2026 (GLOBE NEWSWIRE) -- J-Star Holding Co., Ltd. (Nasdaq: YMAT) ("J-Star" or [...]
Onco360® Has Been Selected as a National Specialty Pharmacy Provider for IMKELDI® (imatinib) Oral Solution
02/06/2026
LOUISVILLE, KY, June 02, 2026 (GLOBE NEWSWIRE) -- Onco360 ® , the nation’s leading independent Specialty Pharmacy, has been selected as a pharmacy partner by Shorla Oncology for IMKELDI ® (imatinib) Oral Solution, [...]
Nanobiotix fait le point sur sa tresorerie et son activite operationnelle pour le premier trimestre 2026
02/06/2026
Réalisation d’une augmentation de capital en mai 2026 pour un montant total d'environ 86,1 million d'euros bruts, incluant l'émission de bons de souscription préfinancés, pour accélérer le développement des autres [...]
CAHI Honours The Honourable Don Boudria for Leadership in Animal Health
02/06/2026
OTTAWA, Ontario, June 02, 2026 (GLOBE NEWSWIRE) -- The Canadian Animal Health Institute (CAHI) is proud to announce the recipients of its 2026 Annual Awards, recognizing exceptional leadership and contributions to [...]
Nanobiotix Provides First Quarter 2026 Operational and Financial Update
02/06/2026
Completed a follow-on offering in May 2026 for aggregate gross proceeds of approximately €86.1 million, including issuance of pre-funded warrants to accelerate the development of Company’s other platforms New data from [...]
Monte Rosa Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/06/2026
BOSTON, June 02, 2026 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced the grant of [...]
KORTUC Launches Global Cervical Cancer Study, Expanding Pipeline to Second Indication
02/06/2026
Led by the University of California San Diego, the clinical trial evaluates the safety and efficacy of KRC-01, a radiosensitizer designed to make solid tumors more susceptible to radiation, under a study protocol [...]
PetMeds® Announces Fourth Quarter and Fiscal Year 2026 Financial Results
02/06/2026
DELRAY BEACH, Fla., June 02, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today announced its financial results for its fourth quarter and fiscal year ended [...]
L’ICSA rend hommage à l’honorable Don Boudria pour son engagement envers la santé animale
02/06/2026
OTTAWA, Ontario, 02 juin 2026 (GLOBE NEWSWIRE) -- L’Institut canadien de la santé animale (ICSA) est fier d’annoncer les lauréats de ses prix annuels 2026, qui récompensent un engagement et des contributions [...]
Texas Original Launches First Medical Marijuana Vaporization Device to Meet Critical Patient Need
02/06/2026
The inhalable delivery option provides a faster onset for patients who cannot ingest edibles, and are managing episodic conditions BASTROP, Texas, June 02, 2026 (GLOBE NEWSWIRE) -- Texas Original , the state’s leading [...]
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/06/2026
NEW YORK and WALTHAM, Mass., June 02, 2026 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the [...]
Alvotech to present at upcoming investor conferences in June
02/06/2026
REYKJAVIK, Iceland, June 02, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for [...]
vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
02/06/2026
HIGH POINT, N.C., June 02, 2026 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company focused on the development of cadisegliatin , a novel, potential first-in-class oral [...]
Physicians Must Be Good Stewards of Their Practice, States the President of the Association of American Physicians and Surgeons (AAPS)
02/06/2026
TUCSON, Ariz., June 02, 2026 (GLOBE NEWSWIRE) -- Maintaining a successful medical practice requires careful stewardship, writes George L. Smith , III, M.D., in the summer issue of the Journal of American Physicians and [...]

Pages